Katy Dodd

@katycdodd.bsky.social

Neurologist researching myasthenia gravis

We're excited to share our latest publication on immune dysfunction in refractory MG! Huge shoutout to the brilliant clinical scientist @katycdodd.bsky.social - from patient recruitment across the country to experiments and data analysis, you did it all! Can't wait to see what you do next 🌟

Bild
Katy Dodd@katycdodd.bsky.social · 8mo ago

What are the immune system changes in refractory Myasthenia Gravis? Read our publication today in Med 🌟 @ncaresearchnhs.bsky.social @fbmh-uom.bsky.social @dns-uom.bsky.social @lydiabeckeriii.bsky.social @neuromuscularmanc.bsky.social @madhvimenon.bsky.social www.sciencedirect.com/science/arti...

We’re delighted to share the publication of our Cochrane Review: Rituximab for myasthenia gravis This systematic review examined the RCT evidence for this B cell depleting therapy in myasthenia, and is now available via the Cochrane Library. 🔗 www.cochranelibrary.com/cdsr/doi/10....

Rituximab for myasthenia gravis - Dodd, KC - 2025 | Cochrane Library

Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.

cochranelibrary.com